From Benzinga's Healthcare Summit: Vivani Medical Co-Founder & CEO, Adam Mendelsohn Says Co Is Not In Clinicals Yet, But Hopes To Be There Soon
Portfolio Pulse from Benzinga Newsdesk
At Benzinga's Healthcare Summit, Vivani Medical's Co-Founder & CEO, Adam Mendelsohn, mentioned that the company is not yet in clinical trials but hopes to start them soon.

March 20, 2024 | 5:26 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Vivani Medical has not entered clinical trials yet but plans to initiate them in the near future, as stated by CEO Adam Mendelsohn.
The news indicates a future milestone for Vivani Medical, which could be significant for its development and valuation. However, without specific timelines or outcomes, the immediate impact on the stock price is likely neutral. The relevance is high as it directly involves the company's core activities, but the importance is moderated by the lack of immediate action or results.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80